Presentation TCT 2014 TCT 481: Two-Year Clinical Results of Patients Randomized to 3- or 12-Month Dual Antiplatelet After Endeavor Zotarolimus-Eluting Stent Implantation in OPTIMIZE Presenter: Dietmar Trenk, Harvey D. White, Dominick J. Angiolillo, Fausto Feres September 14, 2014
Presentation TCT 2014 TCT 479: The Increased Risk of Stent Thrombosis in Acute Coronary Syndromes Is Confined to the First 30 Days After PCI: Results from the Multicenter ADAPT-DES Study Presenter: Dietmar Trenk, Harvey D. White, Dominick J. Angiolillo, Ajay J. Kirtane September 14, 2014
News Daily News Predominan Factores Desconocidos en la Respuesta Variable al Clopidogrel January 16, 2013
Presentation Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms, Noncompliance, Diet, Smoking, Co-medications, and Preexistent Variability in Platelet Func Presenter: Andrew L. Frelinger January 15, 2013
Presentation A Randomized Trial of Prasugrel vs. Clopidogrel in Patients with High Platelet Reactivity on Clopidogrel After Elective PCI with DES Presenter: Dietmar Trenk April 18, 2012
News Daily News Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk L.A. McKeown June 03, 2011